Echo IQFRA:PL4 +25.23%13 PB Ratio is 62.53 as of Jun. 26, 2026, which is 651% above its 10-year median of 8.33. GuruFocus rates FRA:PL4 with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 611 Healthcare Providers & Services companies, Echo IQ ranks worse than 99.67% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Echo IQ's share price is €0.938. Echo IQ's Book Value per Share for the quarter that ended in Dec. 2025 was €0.02. Hence, Echo IQ's PB Ratio of today is 62.53.
The historical rank and industry rank for Echo IQ's PB Ratio or its related term are showing as below:
FRA:PL4'
s PB Ratio Range Over the Past 10 Years
Min: 2.58 Med: 8.33 Max: 70
Current: 46.42
During the past 13 years, Echo IQ's highest PB Ratio was 70.00. The lowest was 2.58. And the median was 8.33.
FRA:PL4's PB Ratio is ranked worse than 99.67% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs FRA:PL4: 46.42
During the past 12 months, Echo IQ's average Book Value Per Share Growth Rate was 58.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 20.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 9.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Echo IQ was 20.50% per year. The lowest was -69.20% per year. And the median was -23.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Echo IQ PB Ratio Related Terms
Echo IQ PB Ratio Historical Data
* Premium members only.
The historical data trend for Echo IQ's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Echo IQ's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Echo IQ PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Echo IQ's PB Ratio distribution charts can be found below:
* The bar in red indicates where Echo IQ's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Echo IQ's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Echo IQ (FRA:PL4) has a PB Ratio of 62.53 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Echo IQ and its competitors. This is 651% above median its historical median of 8.33. Over the past decade, Echo IQ's PB Ratio has ranged from 2.58 to 70.00. According to the industry distribution chart, Echo IQ ranks #609 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 99.7%.
Is Echo IQ's PB Ratio too high?
Echo IQ's current PB Ratio of 62.53 is 651% above median its 10-year median of 8.33. Over the past 10 years, this metric has ranged from a low of 2.58 to a high of 70.00. The Healthcare Providers & Services industry median PB Ratio is 1.98. Echo IQ's value of 62.53 is 3058.1% above this industry median. Based on the distribution chart, Echo IQ ranks #609 out of 611 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Echo IQ has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Echo IQ's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Echo IQ ranks #609 out of 611 companies for PB Ratio. This places Echo IQ in the lower half of its industry. The industry median PB Ratio is 1.98. Echo IQ's value of 62.53 is 3058.1% above this benchmark. Historically, Echo IQ's own PB Ratio has ranged from 2.58 to 70.00 over the past decade. While the company's 10-year median is 8.33 vs. the industry median of 1.98, Echo IQ has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Echo IQ's current PB Ratio of 62.53 is 3058.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Echo IQ and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Echo IQ's current PB Ratio is 62.53, which is 651% above median its own 10-year median of 8.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Echo IQ stock overvalued right now?
Echo IQ (FRA:PL4) has a current PB Ratio of 62.53. The current PB Ratio is 62.53, which is 651% above median its 10-year median of 8.33 and 3058.1% above the Healthcare Providers & Services industry median of 1.98. Echo IQ's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Echo IQ (FRA:PL4), the current PB Ratio is 62.53 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care.
13GF Score
Get the complete analysis for FRA:PL4
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PL4 has been successfully added to your 
